Search research articles
Contact Us
Filters
Showing results (481-490 of 554) with videos related to
Page
of 56
Sort By:
BJU International
|
August 17, 2023
Localised non-metastatic sarcomatoid renal cell carcinoma: a 31-year externally verified study
Kyle A Blum, Andrew W Silagy, Andrea Knezevic, et al.
European Urology
|
March 12, 2021
Predicting Disease Recurrence, Early Progression, and Overall Survival Following Surgical Resection for High-risk Localized and Locally Advanced Renal Cell Carcinoma
Andres F Correa, Opeyemi A Jegede, Naomi B Haas, et al.
Circulation. Heart Failure
|
April 18, 2018
Longitudinal Assessment of Vascular Function With Sunitinib in Patients With Metastatic Renal Cell Carcinoma
Anna B Catino, Rebecca A Hubbard, Julio A Chirinos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 27, 2016
Efficacy of the nanoparticle-drug conjugate CRLX101 in combination with bevacizumab in metastatic renal cell carcinoma: results of an investigator-initiated phase I-IIa clinical trial
S M Keefe, J Hoffman-Censits, R B Cohen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 12, 2026
Hepatocellular Carcinoma Survival in People With and Without HIV in the United States, 2001-2019
Jennifer K McGee-Avila, Cameron B Haas, Jaimie Z Shing, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 27, 2017
A randomized phase II trial of CRLX101 in combination with bevacizumab versus standard of care in patients with advanced renal cell carcinoma
M H Voss, A Hussain, N Vogelzang, et al.
Clinical and Experimental Medicine
|
March 21, 2023
ATPergic signaling disruption in human sepsis as a potential source of biomarkers for clinical use
R O Leite, P O de Souza, C B Haas, et al.
The Plant Journal : for Cell and Molecular Biology
|
November 13, 2019
PEATmoss (Physcomitrella Expression Atlas Tool): a unified gene expression atlas for the model plant Physcomitrella patens
Noe Fernandez-Pozo, Fabian B Haas, Rabea Meyberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 26, 2024
Randomized, Double-Blind Phase III Study of Pazopanib Versus Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease After Metastasectomy: ECOG-ACRIN E2810
Leonard J Appleman, Se Eun Kim, Wayne B Harris, et al.
Cancer Research Communications
|
January 27, 2026
Phase 1 Study of INBRX-105, a TNFRSF9 (4-1BB) and PD-L1 Bispecific Antibody, in Patients With Select Solid Tumors
Jong Chul Park, David Berz, Manish R Sharma, et al.
Page
of 56
Search research articles
Search
Showing results (481-490 of 554) with videos related to
Sort By:
Page
of 56
BJU International
|
August 17, 2023
Localised non-metastatic sarcomatoid renal cell carcinoma: a 31-year externally verified study
Kyle A Blum, Andrew W Silagy, Andrea Knezevic, et al.
European Urology
|
March 12, 2021
Predicting Disease Recurrence, Early Progression, and Overall Survival Following Surgical Resection for High-risk Localized and Locally Advanced Renal Cell Carcinoma
Andres F Correa, Opeyemi A Jegede, Naomi B Haas, et al.
Circulation. Heart Failure
|
April 18, 2018
Longitudinal Assessment of Vascular Function With Sunitinib in Patients With Metastatic Renal Cell Carcinoma
Anna B Catino, Rebecca A Hubbard, Julio A Chirinos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 27, 2016
Efficacy of the nanoparticle-drug conjugate CRLX101 in combination with bevacizumab in metastatic renal cell carcinoma: results of an investigator-initiated phase I-IIa clinical trial
S M Keefe, J Hoffman-Censits, R B Cohen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 12, 2026
Hepatocellular Carcinoma Survival in People With and Without HIV in the United States, 2001-2019
Jennifer K McGee-Avila, Cameron B Haas, Jaimie Z Shing, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 27, 2017
A randomized phase II trial of CRLX101 in combination with bevacizumab versus standard of care in patients with advanced renal cell carcinoma
M H Voss, A Hussain, N Vogelzang, et al.
Clinical and Experimental Medicine
|
March 21, 2023
ATPergic signaling disruption in human sepsis as a potential source of biomarkers for clinical use
R O Leite, P O de Souza, C B Haas, et al.
The Plant Journal : for Cell and Molecular Biology
|
November 13, 2019
PEATmoss (Physcomitrella Expression Atlas Tool): a unified gene expression atlas for the model plant Physcomitrella patens
Noe Fernandez-Pozo, Fabian B Haas, Rabea Meyberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 26, 2024
Randomized, Double-Blind Phase III Study of Pazopanib Versus Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease After Metastasectomy: ECOG-ACRIN E2810
Leonard J Appleman, Se Eun Kim, Wayne B Harris, et al.
Cancer Research Communications
|
January 27, 2026
Phase 1 Study of INBRX-105, a TNFRSF9 (4-1BB) and PD-L1 Bispecific Antibody, in Patients With Select Solid Tumors
Jong Chul Park, David Berz, Manish R Sharma, et al.
Page
of 56